The effectiveness of high-flow nasal cannula and standard non-rebreathing mask for oxygen therapy in moderate category COVID-19 pneumonia: Randomised controlled trial

BACKGROUND: COVID-19 caused by the highly infectious severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is a matter of concern and has led to severe health problems all over the world. Oxygen therapy is the mainstay for the management of patients suffering from various stages of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazir, N, Saxena, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: South African Medical Association 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178776/
https://www.ncbi.nlm.nih.gov/pubmed/35692457
http://dx.doi.org/10.7196/AJTCCM.2022.v28i1.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178776/
https://www.ncbi.nlm.nih.gov/pubmed/35692457
http://dx.doi.org/10.7196/AJTCCM.2022.v28i1.206

Ejemplares similares